Susquehanna International Group’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666K | Sell |
219,897
-54,984
| -20% | -$167K | ﹤0.01% | 3916 |
|
|
2025
Q1 | $1.17M | Buy |
274,881
+56,408
| +26% | +$240K | ﹤0.01% | 3088 |
|
|
2024
Q4 | $1.15M | Buy |
+218,473
| New | +$1.15M | ﹤0.01% | 2785 |
|
|
2024
Q3 | – | Sell |
-10,036
| Closed | -$20.9K | – | 6521 |
|
|
2024
Q2 | $20.9K | Sell |
10,036
-1,149
| -10% | -$2.39K | ﹤0.01% | 5395 |
|
|
2024
Q1 | $44.9K | Buy |
+11,185
| New | +$44.9K | ﹤0.01% | 5189 |
|
|
2023
Q4 | – | Sell |
-34,971
| Closed | -$58.4K | – | 6617 |
|
|
2023
Q3 | $58.4K | Buy |
+34,971
| New | +$58.4K | ﹤0.01% | 5076 |
|
|
2022
Q3 | – | Sell |
-15,969
| Closed | -$47K | – | 6877 |
|
|
2022
Q2 | $47K | Buy |
15,969
+2,230
| +16% | +$6.56K | ﹤0.01% | 5249 |
|
|
2022
Q1 | $70K | Sell |
13,739
-14,123
| -51% | -$72K | ﹤0.01% | 5236 |
|
|
2021
Q4 | $188K | Buy |
27,862
+11,969
| +75% | +$80.8K | ﹤0.01% | 4986 |
|
|
2021
Q3 | $110K | Sell |
15,893
-4,716
| -23% | -$32.6K | ﹤0.01% | 4950 |
|
|
2021
Q2 | $201K | Buy |
+20,609
| New | +$201K | ﹤0.01% | 4839 |
|
|
2020
Q2 | – | Sell |
-18,674
| Closed | -$441K | – | 4905 |
|
|
2020
Q1 | $441K | Buy |
18,674
+18,264
| +4,455% | +$431K | ﹤0.01% | 3014 |
|
|
2019
Q4 | $7K | Sell |
410
-1,491
| -78% | -$25.5K | ﹤0.01% | 3910 |
|
|
2019
Q3 | $20K | Buy |
+1,901
| New | +$20K | ﹤0.01% | 4290 |
|
|
2019
Q1 | – | Sell |
-802
| Closed | -$73K | – | 4449 |
|
|
2018
Q4 | $73K | Buy |
+802
| New | +$73K | ﹤0.01% | 3264 |
|
|
2018
Q2 | – | Sell |
-307
| Closed | -$31K | – | 4656 |
|
|
2018
Q1 | $31K | Sell |
307
-186
| -38% | -$18.8K | ﹤0.01% | 3186 |
|
|
2017
Q4 | $37K | Buy |
+493
| New | +$37K | ﹤0.01% | 3477 |
|
|
2017
Q2 | – | Sell |
-739
| Closed | -$52K | – | 4326 |
|
|
2017
Q1 | $52K | Buy |
+739
| New | +$52K | ﹤0.01% | 3051 |
|